See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Natural Disasters
Education
Social Media
Republican Party
Democratic Party
Senate
Taxes
Artificial Intelligence
Tariffs
Donald Trump
Soccer
Published • loading... • Updated

Bio-Thera, Dr. Reddy’s partner to commercialise BAT2206, a proposed Stelara Biosimilar, and BAT2506, a proposed Simponi Biosimilar - Express Pharma

Summary by Express Pharma
Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories, announce they have reached commercialisation and license agreements for BAT2206, a proposed Stelara Biosimilar, and BAT2506, a proposed Simponi Biosimilar. Under the agreement, Bio-Thera will maintain responsibility for the developmen…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Express PharmaExpress Pharma

Bio-Thera, Dr. Reddy’s partner to commercialise BAT2206, a proposed Stelara Biosimilar, and BAT2506, a proposed Simponi Biosimilar - Express Pharma

Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories, announce they have reached commercialisation and license agreements for BAT2206, a proposed Stelara Biosimilar, and BAT2506, a proposed Simponi Biosimilar. Under the agreement, Bio-Thera will maintain responsibility for the developmen…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Express Pharma broke the news in on Friday, March 28, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal